Targeted antimicrobial use admission provides an actionable denominator for evaluating inpatient length of therapy
Our novel antibiotic use denominator, targeted antimicrobial use admission, is defined as an inpatient admission in which a select agent or group of agents is administered. Used in combination with length of therapy, it allows programs to quickly assess agent inpatient durations.
Authors
- Elizabeth Dodds‐Ashley
- Melissa D. Johnson (ORCID: https://orcid.org/0000-0002-6606-9460)
- Angelina Davis (ORCID: https://orcid.org/0000-0003-4859-5421)
- April Dyer (ORCID: https://orcid.org/0000-0002-0360-8172)
- Rebekah W. Moehring (ORCID: https://orcid.org/0000-0001-7741-6029)
- Travis Jones
Institutions
- Antimicrobial Materials (United States) (US)
Publication Details
- Journal
- Antimicrobial Stewardship & Healthcare Epidemiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/ash.2025.10119
- Primary Topic
- Antibiotic Use and Resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00